Reed Elsevier NV Press Releases

ENL 
$48.11
*  
0.17
0.35%
Get ENL Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading ENL now
Exchange: NYSE
Industry: Consumer Services
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Endo Registration Statement Relating to Pending Auxilium Acquisition Declared Effective by the SEC
12/11/2014 5:00:00 PM - PR Newswire


Endo Completes Acquisition of Rights to Natesto™ Testosterone Nasal Gel
12/9/2014 7:00:00 AM - PR Newswire


New Sports and Fitness Book Published by Elsevier: "The Science of Fitness" Co-Authored by Legendary Cyclist Greg LeMond and Mark Hom, MD
12/4/2014 8:00:00 AM - Market Wire


New Elsevier Reference Module in Biomedical Sciences Now Available
12/3/2014 4:00:00 AM - Market Wire


Endo Acquires Rights to Natesto™ Testosterone Nasal Gel
11/24/2014 7:00:00 AM - PR Newswire


Endo Announces Launch of Generic Version of Valcyte®
11/20/2014 7:30:00 AM - PR Newswire


Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals
11/19/2014 7:30:00 AM - PR Newswire


Elsevier Publishes New Books on Chemical and Process Engineering
11/19/2014 4:00:00 AM - Market Wire


Elsevier Expands Neuroscience Portfolio With Eight New Books
11/17/2014 8:45:00 AM - Market Wire


Sentrian, the World's First Remote Patient Intelligence Company, Launches to Eliminate Preventable Hospitalization
11/10/2014 8:03:00 AM - PR Newswire
▲5.25 % Price Change since this news event. The Volume Ratio is 0.81.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Endo Receives Final Approval for Generic Version of Valcyte®
11/10/2014 8:00:00 AM - PR Newswire


Endo Reports Third Quarter Financial Results
11/5/2014 7:00:00 AM - PR Newswire


Endo to Announce Third Quarter 2014 Financial Results on November 5, 2014
10/20/2014 4:00:00 PM - PR Newswire


LexisNexis: Homegrown Cardiff Company, Tracesmart®, Creates 40 New Jobs in Cardiff
10/15/2014 9:00:00 AM - Business Wire


Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
10/9/2014 6:30:00 AM - PR Newswire


Elsevier Adds Five New Subject Areas to Legacy eBook Collection
10/6/2014 4:00:00 AM - Market Wire


Endo Reaches Master Settlement Agreements to Resolve Substantially All Remaining AMS Mesh Litigation Claims
9/30/2014 5:08:00 PM - PR Newswire